Peptide record

TPDB12147

Antibacterial Anticancer Antifungal Antiparasitic Antiviral standard
46 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB12147
Antibacterial Anticancer Antifungal Antiparasitic Antiviral
Anti-infective peptides Cancer-related peptides
AntiBP3 dbAMP DRAMP Peptipedia AFP-GFuse Antifungipept CAFPdb
standard
No
A 46-aa standard-residue multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIFSKISGKAIKNLFIKGAKNVGKRVGMDVVRTGMDVVGCKIKGEC
Physicochemical Analysis

Sequence-only estimates for a linear peptide with free termini, not experimentally measured molecular properties. Mass and formula exclude cyclization and disulfide formation. The optical estimates assume paired cysteines, 280 nm, 1 g/L and a 1 cm path. The N-end rule estimate is not a measured plasma half-life.

C213H368N62O58S4
QHPWY
GK
4853.89
10.52
10
3
18
+7
0.94
0.137
93.04
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
125
0.03
7
Residue Composition
number
2
A
2
R
2
N
2
D
2
C
1
E
0
Q
8
G
0
H
5
I
1
L
8
K
2
M
2
F
0
P
2
S
1
T
0
W
0
Y
6
V
Amino Acid Distribution
A: 2 R: 2 N: 2 D: 2 C: 2 E: 1 Q: 0 G: 8 H: 0 I: 5 L: 1 K: 8 M: 2 F: 2 P: 0 S: 2 T: 1 W: 0 Y: 0 V: 6
Chemical Descriptors
46 reviewed residue count
C213H368N62O58S4 sequence-only estimate (linear, free termini)
4853.89 sequence-only estimate (linear, free termini)
10.52 sequence-only estimate (linear, free termini)
+7 sequence-only estimate (linear, free termini)
0.94 sequence-only estimate (linear, free termini)
0.137 sequence-only estimate (linear, free termini)
Evidence Records 12 records
Evidence 1 Activity

Activity

MIC
Antibacterial
5.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP

Other

Source Activity Label Source Definition
Antibacterial
dbAMP classified as Antibacterial under the Anti-bacterial function class. DRAMP antibacterial activity supported by MIC records against bacterial target organisms.
Active against Gram- bacteria E. coli (MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 2 Activity

Activity

MIC
Antibacterial
11 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP

Other

MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 3 Activity

Activity

MIC
Antibacterial
11.0 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP

Other

alled P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 4 Activity

Activity

MIC
Antifungal
5.5 µg/mL

Target

Escherichia coli

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

Source Activity Label Source Definition
Antifungal
dbAMP classified under the Anti-fungal function class. DRAMP antifungal activity supported by activity records against fungal target organisms.
Active against Gram- bacteria E. coli (MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 5 Activity

Activity

MIC
Antifungal
11 µg/mL

Target

Staphylococcus aureus

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 6 Activity

Activity

MIC
Antifungal
11.0 µg/mL

Target

Candida albicans

Source & Reference

dbAMP DRAMP CAFPdb Antifungipept

Other

alled P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 7 Activity

Activity

MIC
Antiparasitic
5.5 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiparasitic
DRAMP antiparasitic activity supported by activity records against parasitic targets.
Active against Gram- bacteria E. coli (MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 8 Activity

Activity

MIC
Antiparasitic
11 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 9 Activity

Activity

MIC
Antiparasitic
11.0 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

alled P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 10 Activity

Activity

MIC
Antiviral
5.5 µg/mL

Target

Escherichia coli

Source & Reference

DRAMP

Other

Source Activity Label Source Definition
Antiviral
DRAMP antiviral activity supported by activity records against viral targets.
Active against Gram- bacteria E. coli (MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC
Evidence 11 Activity

Activity

MIC
Antiviral
11 µg/mL

Target

Staphylococcus aureus

Source & Reference

DRAMP

Other

MIC 5.5 ug/ml), B. pyocyaneus (now called P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021
Evidence 12 Activity

Activity

MIC
Antiviral
11.0 µg/mL

Target

Candida albicans

Source & Reference

DRAMP

Other

alled P. aeruginosa) (MIC 11.0 ug/ml), Gram+ bacteria S. aureus (MIC 11 ug/ml), and yeast C. albicans (MIC 11.0 ug/ml). Updated 7/2021